Morgan Stanley raised the firm’s price target on Globus Medical (GMED) to $83 from $74 and keeps an Equal Weight rating on the shares. The company reported “solid” Q3 topline and bottom-line beats, ...

Globus Medical ( (GMED) ) has released its Q3 earnings. Here is a breakdown of the information Globus Medical presented to its investors.

The researchers analyzed brain volume in key subcortical structures, including the brainstem, hippocampus, amygdala, thalamus, nucleus accumbens, putamen, caudate nucleus, globus pallidus and ...

LOS ANGELES, CA / ACCESSWIRE / October 20, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Globus Medical ...